AMRN News and Press, Amarin Corporation plc

2026-03-07 01:35:00 ET Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs. And Vascepa, the one drug it has to sell, is already facing ge...

2026-03-03 09:50:00 ET Broader equities have been relatively volatile over the past few months. In an environment like this, it's best to prioritize investing in well-established, profitable corporations. While small-cap stocks may have higher upside potential than much larger companies...

Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations and fewer days lost due to hospitalization and death, providing additional insights on the effects of IPE on patient-centered measures of total disease burden DUBLIN and BRIDGEWATER, N.J., Marc...

2026-02-25 14:58:00 ET Amarin Corporation plc (AMRN) Q4 2025 Earnings Call February 25, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Amarin Corporation plc (AMRN) Q4 2025 Earnings Call Transcript

2026-02-25 10:38:16 ET Image source: The Motley Fool. Feb. 25, 2026 Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-25 10:17:23 ET More on Amarin Amarin expects full-year 2025 revenue in-line with estimates Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Amarin Read the full article on Seeking Al...

2026-02-25 07:02:22 ET More on Amarin Amarin expects full-year 2025 revenue in-line with estimates Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Amarin Read the full article on Seeking Al...

Strategic Initiatives and Refined Business Model Produced Financial and Operating Efficiencies Established Long-Term License and Supply Agreement to Commercialize VAZKEPA® Across Europe and Sustained U.S. Market Leadership for VASCEPA® Franchise Total of 45 Publications...

HCI Group Inc. (HCI) is expected to report $4.87 for Q4 2025 XPEL Inc. (XPEL) is expected to report $0.43 for Q4 2025 Oversea-Chinese Banking Corporation Limited ADR (OVCHY) is expected to report $0.56 for Q4 2025 UMH Properties Inc. (UMH) is expected to report $0.24 for Q4 2025 I...

2026-02-24 10:08:28 ET More on Amarin Amarin expects full-year 2025 revenue in-line with estimates Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Amarin Read the full article on Seeking Al...